Work

Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019

Year: 2019

Type: article

Abstract: This study describes point-of-sale prices for orally administered anticancer drugs offered through Medicare Part D and out-of-pocket changes in spending as a result of decreasing coinsurance and price changes between 2010 and 2019.

Source: JAMA

DOI: 10.1001/jama.2019.4492

Authors: Stacie B. Dusetzina, Haiden A. Huskamp, Nancy L. Keating

Institutions: Vanderbilt University, Harvard University

Language: English

Topic: Economic and Financial Impacts of Cancer

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Commonwealth Fund, Leukemia and Lymphoma Society, Laura and John Arnold Foundation

OpenAlex ID: W2947451630

FWCI: 20.78

Cites: 5

Cited by: 92

Related to: 10